Zymergen
Latest round
- Series D
Last raised
- Sep 2020
Total raised
- $882M
Investors
- 18
About Zymergen
Zymergen, Inc. specializes in biotechnology, creating advanced materials and products through innovative biological processes.03 mn. The firm was co-founded by Josh Hoffman and Zach Serber, with Jay Flatley serving as CEO. In July 2022, Zymergen was acquired by Ginkgo BioWorks, Inc.Zymergen, Inc. provides a range of biotechnology solutions aimed at various sectors, including agriculture and biopharma. The company develops innovative materials and products utilizing genetic engineering and advanced biological processes. Key offerings include AI-driven models for optimizing production, lab automation systems, and customized R&D services tailored to the specific needs of clients in the agricultural and pharmaceutical industries.In 2021, Zymergen, Inc.74 mn.Following its IPO on April 21, 2021, Zymergen, Inc.03 mn to accelerate the production of its Hyaline film and expedite the commercialization of other products. The company aims to expand its operations into new markets, specifically targeting regions in Asia and Europe by the end of 2023. The acquisition by Ginkgo BioWorks, completed in October 2022, is expected to further enhance Zymergen's capabilities and market reach, supporting its strategic initiatives to develop new biotechnology solutions.
Who invested in Zymergen
18 investors across 5 rounds
See all investors in Zymergen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zymergen
Who invested in Zymergen?
Zymergen has 18 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zymergen raised?
Zymergen has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Zymergen last raise money?
Zymergen's most recent round on record is a Series D, in Sep 2020.
What does Zymergen do?
Zymergen is a biotechnology company.
Where is Zymergen headquartered?
Zymergen is headquartered in Emeryville, US.
Which VCs invest in companies like Zymergen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zymergen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Zymergen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.